{"id":840211,"date":"2025-04-22T16:23:49","date_gmt":"2025-04-22T20:23:49","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\/"},"modified":"2025-04-22T16:23:49","modified_gmt":"2025-04-22T20:23:49","slug":"heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\/","title":{"rendered":"Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">CARY, N.C.<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">April 22, 2025<\/span><\/span> \/PRNewswire\/ &#8212; Heron Therapeutics, Inc. (Nasdaq: HRTX) (&#8220;Heron&#8221; or the &#8220;Company&#8221;), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on <span class=\"xn-chron\">Tuesday, May 6, 2025<\/span>, at <span class=\"xn-chron\">8:00 a.m. ET<\/span> to report first quarter 2025 financial results and discuss recent business highlights.<\/p>\n<p>The conference call can be accessed by phone by utilizing the following\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4410402-1&amp;h=3233411705&amp;u=https%3A%2F%2Fnam12.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fregister-conf.media-server.com%252Fregister%252FBI8c8ed1d304f948ecac5ee2cdc4ca9920%26data%3D05%257C02%257Cmjarel%2540herontx.com%257Cbfa63b3bf1d84c6a587308dd80df2c70%257C198652f1a0b3423d8eb89ad683090d53%257C0%257C0%257C638808418253051438%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C0%257C%257C%257C%26sdata%3DkFKGqopH4mEifbuq2TA5OmJckFVc2DRrWtMrf4kNntU%253D%26reserved%3D0&amp;a=registration+link\" target=\"_blank\" rel=\"nofollow\">registration link<\/a>\u00a0which will provide participants with dial-in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The conference call will also be available via webcast under the Investor Relations section of Heron&#8217;s website at\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4410402-1&amp;h=1155923926&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4289683-1%26h%3D964777311%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D2382300-1%2526h%253D3418578330%2526u%253Dhttp%25253A%25252F%25252Fwww.herontx.com%25252F%2526a%253Dwww.herontx.com%26a%3Dwww.herontx.com&amp;a=www.herontx.com\" target=\"_blank\" rel=\"nofollow\">www.herontx.com<\/a>. An archive of the teleconference and webcast will also be made available on Heron&#8217;s website for 60 days following the call.<\/p>\n<p>\n        <b>About\u00a0Heron Therapeutics, Inc.<\/b>\n      <\/p>\n<p>Heron Therapeutics, Inc.\u00a0is a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. For more information, visit\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4410402-1&amp;h=588086972&amp;u=http%3A%2F%2Fwww.herontx.com%2F&amp;a=www.herontx.com\" target=\"_blank\" rel=\"nofollow\">www.herontx.com<\/a>.<\/p>\n<p>\n        <b>Forward-looking Statements<\/b>\n      <\/p>\n<p>This news release contains &#8220;forward-looking statements&#8221; as defined by the Private Securities Litigation Reform Act of 1995. Heron cautions readers that forward-looking statements are based on management&#8217;s expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, but are not limited to, risks and uncertainties identified in the Company&#8217;s filings with the\u00a0Securities and Exchange Commission. Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or revise these statements except as may be required by law.<\/p>\n<p>\n        <b>Investor Relations and Media Contact:<\/b>\n      <\/p>\n<p>\n        <span class=\"xn-person\">Ira Duarte<\/span><br \/>\n        <br \/>Executive Vice President, Chief Financial Officer<br \/>Heron Therapeutics, Inc.<br \/><a href=\"mailto:iduarte@herontx.com\" target=\"_blank\" rel=\"nofollow\">iduarte@herontx.com<\/a><br \/>858-251-4400<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1426\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1874825\/Heron_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1874825\/Heron_Logo.jpg\" title=\"(PRNewsfoto\/Heron Therapeutics, Inc.)\" alt=\"(PRNewsfoto\/Heron Therapeutics, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA69967&amp;sd=2025-04-22\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025-302434958.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025-302434958.html<\/a><\/p>\n<p>SOURCE  Heron Therapeutics, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LA69967&amp;Transmission_Id=202504221605PR_NEWS_USPR_____LA69967&amp;DateId=20250422\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire CARY, N.C. , April 22, 2025 \/PRNewswire\/ &#8212; Heron Therapeutics, Inc. (Nasdaq: HRTX) (&#8220;Heron&#8221; or the &#8220;Company&#8221;), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Tuesday, May 6, 2025, at 8:00 a.m. ET to report first quarter 2025 financial results and discuss recent business highlights. The conference call can be accessed by phone by utilizing the following\u00a0registration link\u00a0which will provide participants with dial-in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The conference call will also be available via webcast under the Investor Relations section of Heron&#8217;s website at\u00a0www.herontx.com. An archive of the teleconference and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-840211","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire CARY, N.C. , April 22, 2025 \/PRNewswire\/ &#8212; Heron Therapeutics, Inc. (Nasdaq: HRTX) (&#8220;Heron&#8221; or the &#8220;Company&#8221;), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Tuesday, May 6, 2025, at 8:00 a.m. ET to report first quarter 2025 financial results and discuss recent business highlights. The conference call can be accessed by phone by utilizing the following\u00a0registration link\u00a0which will provide participants with dial-in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The conference call will also be available via webcast under the Investor Relations section of Heron&#8217;s website at\u00a0www.herontx.com. An archive of the teleconference and &hellip; Continue reading &quot;Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-22T20:23:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1874825\/Heron_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025\",\"datePublished\":\"2025-04-22T20:23:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\\\/\"},\"wordCount\":364,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1874825\\\/Heron_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\\\/\",\"name\":\"Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1874825\\\/Heron_Logo.jpg\",\"datePublished\":\"2025-04-22T20:23:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1874825\\\/Heron_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1874825\\\/Heron_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\/","og_locale":"en_US","og_type":"article","og_title":"Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025 - Market Newsdesk","og_description":"PR Newswire CARY, N.C. , April 22, 2025 \/PRNewswire\/ &#8212; Heron Therapeutics, Inc. (Nasdaq: HRTX) (&#8220;Heron&#8221; or the &#8220;Company&#8221;), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Tuesday, May 6, 2025, at 8:00 a.m. ET to report first quarter 2025 financial results and discuss recent business highlights. The conference call can be accessed by phone by utilizing the following\u00a0registration link\u00a0which will provide participants with dial-in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The conference call will also be available via webcast under the Investor Relations section of Heron&#8217;s website at\u00a0www.herontx.com. An archive of the teleconference and &hellip; Continue reading \"Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-22T20:23:49+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1874825\/Heron_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025","datePublished":"2025-04-22T20:23:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\/"},"wordCount":364,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1874825\/Heron_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\/","name":"Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1874825\/Heron_Logo.jpg","datePublished":"2025-04-22T20:23:49+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1874825\/Heron_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1874825\/Heron_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/840211","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=840211"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/840211\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=840211"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=840211"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=840211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}